Marta Simone

Bari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 04, 2026

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 02, 2026

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Journal: Neurology

Published: May 29, 2026

Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.

Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.

Journal: Journal of neurology

Published: May 18, 2026

Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk.

Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk.

Journal: Neurology and therapy

Published: February 16, 2026

Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

Journal: Neurology

Published: November 24, 2025

Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.

Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.

Journal: Journal of neurology

Published: November 18, 2025

Selective Plasmatic Amino Acid Alterations as a Potential Biomarker for Pathological Stratification in Autism Spectrum Disorders.

Selective Plasmatic Amino Acid Alterations as a Potential Biomarker for Pathological Stratification in Autism Spectrum Disorders.

Journal: Biomedicines

Published: November 13, 2025

Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE Study.

Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE Study.

Journal: Neurology and therapy

Published: October 29, 2025

Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.

Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.

Journal: Neurology

Published: September 22, 2025

Refining Prognostic Factors in Adult-Onset Multiple Sclerosis: A Narrative Review of Current Insights.

Refining Prognostic Factors in Adult-Onset Multiple Sclerosis: A Narrative Review of Current Insights.

Journal: International journal of molecular sciences

Published: June 30, 2025

Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis.

Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 19, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026